Drug – bio-affecting and body treating compositions – Lymphokine
Reexamination Certificate
2005-12-27
2005-12-27
Weber, Jon (Department: 1653)
Drug, bio-affecting and body treating compositions
Lymphokine
C424S134100, C424S810000, C514S002600, C514S012200, C514S885000, C514S921000, C530S350000, C530S351000
Reexamination Certificate
active
06979442
ABSTRACT:
This invention relates to stabilized protein compositions, methods for preparing such stabilized protein compositions, dosage forms for administering such stabilized protein compositions to mammals and methods for preventing or treating infections in mammals by administering such protein compositions to mammals. More particularly, the stabilized protein compositions of the present invention contain therapeutically effective amounts of G-CSF, such as bovine G-CSF, in combination with a stabilizing buffer, such as HEPES, TES or TRICINE, for treating and preventing infections, including mastitis, in cattle.
REFERENCES:
patent: 4623717 (1986-11-01), Fernandes et al.
patent: 4645830 (1987-02-01), Yasushi et al.
patent: 4647454 (1987-03-01), Cymbalista
patent: 4675184 (1987-06-01), Hasegawa et al.
patent: 4810643 (1989-03-01), Souza
patent: 4833127 (1989-05-01), Ono et al.
patent: 4992271 (1991-02-01), Fernandes et al.
patent: 5104651 (1992-04-01), Boone et al.
patent: 5290764 (1994-03-01), Duke, Jr. et al.
patent: 5366964 (1994-11-01), Lindstrom et al.
patent: 5472857 (1995-12-01), Boone et al.
patent: 5503827 (1996-04-01), Woog et al.
patent: 5567677 (1996-10-01), Castensson et al.
patent: 5580856 (1996-12-01), Prestrelski et al.
patent: 5606024 (1997-02-01), Boone et al.
patent: 5661125 (1997-08-01), Strickland
patent: 5681814 (1997-10-01), Clark et al.
patent: 5696086 (1997-12-01), Avraham et al.
patent: 5747447 (1998-05-01), Swift et al.
patent: 0080879 (1983-06-01), None
patent: 0612846 (1994-08-01), None
patent: 0719860 (1996-07-01), None
patent: 2 193 631 (1988-02-01), None
patent: 2193631 (1988-02-01), None
patent: 259333 (1992-12-01), None
patent: 268441 (1993-06-01), None
patent: 271873 (1993-08-01), None
patent: 8604506 (1986-08-01), None
patent: 8604606 (1986-08-01), None
patent: 8702060 (1987-04-01), None
patent: 9414466 (1993-12-01), None
Hammond et al., Blood (1990) 76(3):523-532.
Lovejoy et al., Journal of Molecular Biology (1993) 234(3):640-653.
Gietz et al, Sustained release of injectable zinc-recombinant hirudin suspensions: development and validation of in vitro release, Eur. J. Pharamceutics and Biopharmaceutics (May 1998) 45(3):259-64.
Lovejoy et al., Journal of Molecular Biology, vol. 23, No. 3, pp. 640-653, 1993.
Calibiochem, “Buffers: A guide for the preparation and use ofbuffers in biological systems,” Edited by Donald E. Gueffroy, Calbiochem-Behring Corp, Fourth printing, pp. 1-24, 1981.such features (i.e., methods of increasing effect of immune response to patho.
Nagata, et al.; Nature; vol. 319; pp. 415-418; Molecular cloning and expression cDNA for human granulocyte colony-stimulating factor; (1986).
Canning Peter C.
Kamicker Barbara J.
Kasraian Kasra
Kohn Kenneth I.
Kohn & Associates PLLC
Mohamed Abdel A.
Pfizer Inc.
Pfizer Products Inc.
LandOfFree
Stabilized protein compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized protein compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized protein compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3516912